K562 cells express the BCR/ABL fusion oncogenic tyrosine kinase that causes genomic instability and drug resistance of human leukemia by modulating DNA repair (Blasiak et al., 2002; Majsterek et al. 2002; Slupianek et al., 2002;). Here, BCR is linked to leukemia.